The EFPIA Code on Disclosure of Transfers of Value from pharmaceutical companies to healthcare professionals and healthcare organizations (EFPIA Disclosure Code) established a series of disclosure obligations for its member companies and for the pharmaceutical companies affiliated with its national associations.

Who?

Companies are required to document and disclose any transfers of value they make, directly or indirectly, to or for the benefit of a healthcare professional or a healthcare organization.

What?

The EFPIA Disclosure Code defines "Transfers of Value" as direct and indirect transfers of value, whether in cash, in kind or otherwise, made, whether for promotional purposes or otherwise, in connection with the development and sale of generic or branded prescription-only medicinal products exclusively for human use.

For Transfers of Value to an HCO: donations and grants; contributions to costs related to events and fees for services and consultancy arrangements.

For Transfers of Value to an HCP: contributions to costs related to events and fees for services and consultancy arrangements.

When?

The first reporting period started on 1 January 2015. Disclosures shall be made for the first time in 2016 (no later than 30 June 2016).

How?

Disclosure shall be made at a national level and pursuant to the national codes provisions. The EFPIA Disclosure Code includes a template for disclosure, which has been adopted by the national member association.